EMEA-002015-PIP01-16

Key facts

Active substance
Terguride (hydrogenmaleate)
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0349/2016
PIP number
EMEA-002015-PIP01-16
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Treatment of systemic sclerosis
Route(s) of administration
Oral use
Contact for public enquiries
medac Gesellschaft für klinische Spezialpräparate mbH

Germany
E-mail: dra@medac.de
Tel.: +49 401380060
Fax: +49 401380068255

Decision type
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)

Decision

How useful was this page?

Add your rating